-
EP1379252
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1379252
| EP1379252 - NOCICEPTIN ANALOGS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.11.2014 Database last updated on 26.06.2024 | Most recent event Tooltip | 14.11.2014 | Application deemed to be withdrawn | published on 17.12.2014 [2014/51] | Applicant(s) | For all designated states EURO-CELTIQUE S.A. 2, avenue Charles de Gaulle 1653 Luxembourg / LU | [2008/23] |
| Former [2004/24] | For all designated states EURO-CELTIQUE S.A. 122, Boulevard de la Pétrusse 2330 Luxembourg / LU | ||
| Former [2004/03] | For all designated states Euro-Celtique S.A. 122 Boulevard de la Pétrusse 2330 Luxembourg / LU | Inventor(s) | 01 /
GOEHRING, Richard, R. 6195 Potters Lane Pipersville, PA 18947 / US | 02 /
CHEN, Zhengming 11 Hudnut Lane Belle Mead, NJ 08502 / US | 03 /
KYLE, Donald 29 Weatherfield Drive Newtown, PA 18940 / US | 04 /
VICTORY, Sam 55 Quince Circle Newtown, PA 18940 / US | 05 /
GHARAGOZLOO, Parviz 16 Blue Spruce Drive Pennington, NJ 08534 / US | 06 /
WHITEHEAD, John 155 North State Street Newtown, PA 18940 / US | [2004/03] | Representative(s) | Maiwald, Walter Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2004/03] | Maiwald, Walter, Dr. Dipl.-Chem. Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | Application number, filing date | 02731427.7 | 18.04.2002 | [2004/03] | WO2002US12356 | Priority number, date | US20010284674P | 18.04.2001 Original published format: US 284674 P | US20010284676P | 18.04.2001 Original published format: US 284676 P | [2004/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02085291 | Date: | 31.10.2002 | Language: | EN | [2002/44] | Type: | A2 Application without search report | No.: | EP1379252 | Date: | 14.01.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.10.2002 takes the place of the publication of the European patent application. | [2004/03] | Search report(s) | International search report - published on: | US | 20.02.2003 | (Supplementary) European search report - dispatched on: | EP | 19.09.2005 | Classification | IPC: | A61K31/55, C07D417/04, C07D401/04, A61P25/00 | [2005/44] | CPC data not yet available |
| Former IPC [2004/03] | A61K31/55 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/03] | Extension states | AL | 17.10.2003 | LT | 17.10.2003 | LV | 17.10.2003 | MK | 17.10.2003 | RO | 17.10.2003 | SI | 17.10.2003 | Title | German: | NOCICEPTIN-ANALOGE | [2014/09] | English: | NOCICEPTIN ANALOGS | [2004/03] | French: | ANALOGUES DE LA NOCICEPTINE | [2004/03] |
| Former [2004/03] | NOCICEPTIN-ANALOGA | Entry into regional phase | 17.10.2003 | National basic fee paid | 17.10.2003 | Search fee paid | 17.10.2003 | Designation fee(s) paid | 17.10.2003 | Examination fee paid | Examination procedure | 12.11.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 17.10.2003 | Examination requested [2004/03] | 01.09.2006 | Despatch of a communication from the examining division (Time limit: M06) | 05.03.2007 | Reply to a communication from the examining division | 21.05.2007 | Despatch of a communication from the examining division (Time limit: M04) | 26.09.2007 | Reply to a communication from the examining division | 19.03.2009 | Despatch of a communication from the examining division (Time limit: M04) | 16.07.2009 | Reply to a communication from the examining division | 10.03.2010 | Despatch of a communication from the examining division (Time limit: M03) | 09.06.2010 | Reply to a communication from the examining division | 27.07.2010 | Despatch of a communication from the examining division (Time limit: M02) | 30.09.2010 | Reply to a communication from the examining division | 02.03.2012 | Despatch of a communication from the examining division (Time limit: M04) | 22.06.2012 | Reply to a communication from the examining division | 05.07.2013 | Despatch of a communication from the examining division (Time limit: M04) | 10.10.2013 | Reply to a communication from the examining division | 03.02.2014 | Communication of intention to grant the patent | 14.06.2014 | Application deemed to be withdrawn, date of legal effect [2014/51] | 25.07.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2014/51] | Divisional application(s) | EP08015057.6 / EP1997818 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.09.2006 | Fees paid | Renewal fee | 17.03.2004 | Renewal fee patent year 03 | 15.04.2005 | Renewal fee patent year 04 | 27.03.2006 | Renewal fee patent year 05 | 10.04.2007 | Renewal fee patent year 06 | 18.03.2008 | Renewal fee patent year 07 | 07.04.2009 | Renewal fee patent year 08 | 15.03.2010 | Renewal fee patent year 09 | 06.04.2011 | Renewal fee patent year 10 | 19.03.2012 | Renewal fee patent year 11 | 26.03.2013 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 30.04.2014 | 13 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP0029707 (KYOWA HAKKO KOGYO KK [JP]) [X] 1,2 * example 41; claim -; tables 6,8; compounds II-7,II-9 *; | [X]JPS5759889 (KYOWA HAKKO KOGYO KK) [X] 1,2,7,20-32 * claim -; tables 1,2 *; | [X]EP0382185 (OTSUKA PHARMA CO LTD [JP]) [X] 33,34,39,50-55 * the whole document *; | [X]WO9502405 (MERCK & CO INC [US], et al) [X] 33,34,39,50-55 * page 0; examples 264-269; claim - *; | [X] - TETSUO NISHIKAWA ET AL., "short term clinical trial of 1-{1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl}-3,4-dihydro-2(1h)-quinolinone in patients with diabetic nephropathy.", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH., DEEDITIO CANTOR VERLAG, AULENDORF., (1996), vol. 46, no. II, pages 875 - 878, XP002945529 [X] 33,34,39,50-55 * page 875 - page 878 * | [X] - W. KLEIN, "darstellung von 1-(piperidinyl-4-)indolinonen-(2) u. 3,4-dihydrocarbostyrilen.", ARCH. PHARMAZIE, weinheim, (1975), vol. 307, no. 5, pages 360 - 366, XP000603389 [X] 33,34,39,50-55 * page 360 - page 366 * DOI: http://dx.doi.org/10.1002/ardp.19743070509 | [X] - H.OGAWA ET AL., "orally active, nonpeptide vasopressin V1 antagonists. a novel series of 1-(1-subst. 4-piperidyl) 3,4-dihydro-2(1h)-quinolinone.", JOURNAL OF MEDICINAL CHEMISTRY., USAMERICAN CHEMICAL SOCIETY. WASHINGTON., (1993), vol. 36, no. 14, pages 2011 - 2017, XP002343990 [X] 33,34,39,50-55 * page 2011 - page 2016 * DOI: http://dx.doi.org/10.1021/jm00066a010 | [X] - A. TAHARA ET AL., "characterization of rodent liver a. kidney AVP receptors:", REGULATORY PEPTIDES, us, (1999), vol. 84, pages 13 - 19, XP002343991 [X] 33,34,39,50-55 * page 13 - page 14; compounds OPC-21268 * DOI: http://dx.doi.org/10.1016/S0167-0115(99)00059-2 | International search | [X]JPS60120872 (KYOWA HAKKO KOGYO KK); | [X]US5767118 (NARGUND RAVI [US], et al); | [X]JPH10330377 (KYOWA HAKKO KOGYO KK); | [X]US6063796 (YANG LIHU [US], et al); | [XP]WO0144213 (ASTRAZENECA AB [SE], et al); | [XP]WO0220011 (ORTHO MCNEIL PHARM INC [US]); | [X] - TAKAI ET AL., "Synthesis and pharmacological evaluation of piperidine derivatives with various heterocyclic rings at the 4-position", CHEMICAL PHARMACEUTICAL BULLETIN, (198503), vol. 33, no. 3, pages 1104 - 1115, XP002958543 | by applicant | - TAKAI ET AL., "the synthesis and pharmacological evaluation of piperidine derivatives with various heterocyclic rings at the 4-position", CHEMICAL PHARMACEUTICAL BULLETIN, (198503), vol. 33, no. 3 | - Pharmaceutical Dosage Forms: Tablets, MARCEL DEKKER, INC |